Iranian Journal of Pediatrics

Published by: Kowsar

The Effects of Oral Ibuprofen on Medicinal Closure of Patent Ductus Arteriosus in Full-Term Neonates in the Second Postnatal Week

Mohammad Reza Alipour 1 , Mansooreh Mozaffari Shamsi 1 , Seyedeh Mahdieh Namayandeh 1 , Zohreh Pezeshkpour 1 , Fatemeh Rezaeipour 1 , * and Mohammadtaghi Sarebanhassanabadi 1
Authors Information
1 Yazd Cardiovascular Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, IR Iran
Article information
  • Iranian Journal of Pediatrics: August 2016, 26 (4); e5807
  • Published Online: July 11, 2016
  • Article Type: Research Article
  • Received: February 26, 2016
  • Revised: May 15, 2016
  • Accepted: June 9, 2016
  • DOI: 10.5812/ijp.5807

To Cite: Alipour M R, Mozaffari Shamsi M, Namayandeh S M, Pezeshkpour Z, Rezaeipour F, et al. The Effects of Oral Ibuprofen on Medicinal Closure of Patent Ductus Arteriosus in Full-Term Neonates in the Second Postnatal Week, Iran J Pediatr. 2016 ; 26(4):e5807. doi: 10.5812/ijp.5807.

Abstract
Copyright © 2016, Growth & Development Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnote
References
  • 1. Swartz EN. Is indomethacin or ibuprofen better for medical closure of the patent ductus arteriosus? Arch Dis Child. 2003; 88(12): 1134-5[PubMed]
  • 2. Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr. 2002; 161(4): 202-7[PubMed]
  • 3. Allen HD, Driscoll DJ, Shaddy RE, Feltes TF. Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult 2013;
  • 4. AM R. The ductus arteriosus and persistent patency of the ductus arteriosus. 2001;
  • 5. Alzamora-Castro V, Battilana G, Abugattas R, Sialer S. Patent ductus arteriosus and high altitude. Am J Cardiol. 1960; 5: 761-3[PubMed]
  • 6. Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics. 2003; 112(5)[PubMed]
  • 7. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thailand . 2002; 85(4)-8
  • 8. McIntyre JOB, van den Anker JN. Indomethacin Treatment of Patent Ductus Arteriosus in Premature Infants. Paediatr Perinat Drug Ther. 2001; 4(3): 85-91
  • 9. Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation. 1971; 43(3): 323-32[PubMed]
  • 10. Amoozgar H, Ghodstehrani M, Pishva N. Oral ibuprofen and ductus arteriosus closure in full-term neonates: a prospective case-control study. Pediatr Cardiol. 2010; 31(1): 40-3[DOI][PubMed]
  • 11. Jones RW, Pickering D. Persistent ductus arteriosus complicating the respiratory distress syndrome. Arch Dis Child. 1977; 52(4): 274-81[PubMed]
  • 12. Grosfeld JL, Chaet M, Molinari F, Engle W, Engum SA, West KW, et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg. 1996; 224(3): 350-5[PubMed]
  • 13. Thomas RL, Parker GC, Van Overmeire B, Aranda JV. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr. 2005; 164(3): 135-40[DOI][PubMed]
  • 14. Van Overmeire B, Follens I, Hartmann S, Creten WL, Van Acker KJ. Treatment of patent ductus arteriosus with ibuprofen. Arch Dis Child Fetal Neonatal Ed. 1997; 76(3)-84[PubMed]
  • 15. Jameii Khosroshahi A, Kianfar A, Mohammadpour Aharanjani B, Sayadpour Zanjani K. Usefulness of serum brain natriuretic Peptide level for screening hemodynamically significant patent ductus arteriosus in preterm neonates. Iran J Pediatr. 2014; 24(6): 766-9[PubMed]
  • 16. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998; 135(5 Pt 1): 825-32[PubMed]
  • 17. Pistulli E, Hamiti A, Buba S, Hoxha A, Kelmendi N, Vyshka G. The Association between Patent Ductus Arteriosus and Perinatal Infection in A Group of Low Birth Weight Preterm Infants. Iran J Pediatr. 2014; 24(1): 42-8[PubMed]
  • 18. Pourarian S, Rezaie M, Amoozgar H, Shakiba AM, Edraki MR, Mehdizadegan N. High-Dose Oral Ibuprofen in Treatment of Patent Ductus Arteriosus in Full-Term Neonates. Iran J Pediatr. 2015; 25(4)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments